• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

MYC活性的短暂过量可引发基因组不稳定和肿瘤发生。

Transient excess of MYC activity can elicit genomic instability and tumorigenesis.

作者信息

Felsher D W, Bishop J M

机构信息

Division of Hematology-Oncology, Department of Medicine, University of California, San Francisco 94143-1270, USA.

出版信息

Proc Natl Acad Sci U S A. 1999 Mar 30;96(7):3940-4. doi: 10.1073/pnas.96.7.3940.

DOI:10.1073/pnas.96.7.3940
PMID:10097142
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC22399/
Abstract

Overexpression of the MYC protooncogene has been implicated in the genesis of diverse human tumors. Tumorigenesis induced by MYC has been attributed to sustained effects on proliferation and differentiation. Here we report that MYC may also contribute to tumorigenesis by destabilizing the cellular genome. A transient excess of MYC activity increased tumorigenicity of Rat1A cells by at least 50-fold. The increase persisted for >30 days after the return of MYC activity to normal levels. The brief surfeit of MYC activity was accompanied by evidence of genomic instability, including karyotypic abnormalities, gene amplification, and hypersensitivity to DNA-damaging agents. MYC also induced genomic destabilization in normal human fibroblasts, although these cells did not become tumorigenic. Stimulation of Rat1A cells with MYC accelerated their passage through G1/S. Moreover, MYC could force normal human fibroblasts to transit G1 and S after treatment with N-(phosphonoacetyl)-L-aspartate (PALA) at concentrations that normally lead to arrest in S phase by checkpoint mechanisms. Instead, the cells subsequently appeared to arrest in G2. We suggest that the accelerated passage through G1 was mutagenic but that the effect of MYC permitted a checkpoint response only after G2 had been reached. Thus, MYC may contribute to tumorigenesis through a dominant mutator effect.

摘要

MYC原癌基因的过表达与多种人类肿瘤的发生有关。MYC诱导的肿瘤发生归因于对细胞增殖和分化的持续影响。在此我们报告,MYC也可能通过破坏细胞基因组的稳定性来促进肿瘤发生。短暂的MYC活性过剩使Rat1A细胞的致瘤性增加了至少50倍。在MYC活性恢复到正常水平后,这种增加持续了超过30天。MYC活性的短暂过剩伴随着基因组不稳定的证据,包括核型异常、基因扩增以及对DNA损伤剂的超敏反应。MYC也在正常人成纤维细胞中诱导基因组不稳定,尽管这些细胞没有变成致瘤性细胞。用MYC刺激Rat1A细胞加速了它们通过G1/S期的进程。此外,在通常会通过检查点机制使细胞停滞在S期的浓度下用N-(膦酰乙酰基)-L-天冬氨酸(PALA)处理后,MYC能迫使正常人成纤维细胞通过G1期和S期。相反,这些细胞随后似乎停滞在G2期。我们认为,加速通过G1期具有致突变性,但MYC的作用仅在到达G2期后才允许产生检查点反应。因此,MYC可能通过显性突变效应促进肿瘤发生。

相似文献

1
Transient excess of MYC activity can elicit genomic instability and tumorigenesis.MYC活性的短暂过量可引发基因组不稳定和肿瘤发生。
Proc Natl Acad Sci U S A. 1999 Mar 30;96(7):3940-4. doi: 10.1073/pnas.96.7.3940.
2
Neoplastic transformation and tumorigenesis by the human protooncogene MYC.人类原癌基因MYC导致的肿瘤转化和肿瘤发生。
Proc Natl Acad Sci U S A. 1990 Mar;87(6):2102-6. doi: 10.1073/pnas.87.6.2102.
3
Overexpression of MYC causes p53-dependent G2 arrest of normal fibroblasts.MYC的过表达导致正常成纤维细胞发生p53依赖的G2期阻滞。
Proc Natl Acad Sci U S A. 2000 Sep 12;97(19):10544-8. doi: 10.1073/pnas.190327097.
4
c-MYC overexpression in Ba/F3 cells simultaneously elicits genomic instability and apoptosis.c-MYC在Ba/F3细胞中的过表达同时引发基因组不稳定和细胞凋亡。
Oncogene. 2002 May 2;21(19):2981-90. doi: 10.1038/sj.onc.1205274.
5
Defective double-strand DNA break repair and chromosomal translocations by MYC overexpression.MYC过表达导致双链DNA断裂修复缺陷和染色体易位。
Proc Natl Acad Sci U S A. 2003 Aug 19;100(17):9974-9. doi: 10.1073/pnas.1732638100. Epub 2003 Aug 8.
6
S-cells from a highly N-myc-amplified neuroblastoma are tumorigenic in nude mice.来自高度N-myc扩增神经母细胞瘤的S细胞在裸鼠中具有致瘤性。
Anticancer Res. 1993 Nov-Dec;13(6A):2031-6.
7
Decreased tumorigenicity of c-Myc-transformed fibroblasts expressing active USF2.表达活性USF2的c-Myc转化成纤维细胞的致瘤性降低。
Exp Cell Res. 2005 Jan 1;302(1):1-10. doi: 10.1016/j.yexcr.2004.08.013.
8
Nontumorigenic squamous cell carcinoma line converted to tumorigenicity with methyl methanesulfonate without activation of HRAS or MYC.非致瘤性鳞状细胞癌系经甲磺酸甲酯转化为致瘤性,且未激活HRAS或MYC。
Proc Natl Acad Sci U S A. 1990 Feb;87(4):1268-72. doi: 10.1073/pnas.87.4.1268.
9
Myc/p53 interactions in transgenic mouse mammary development, tumorigenesis and chromosomal instability.Myc与p53在转基因小鼠乳腺发育、肿瘤发生及染色体不稳定性中的相互作用
Oncogene. 1998 May 28;16(21):2755-66. doi: 10.1038/sj.onc.1201804.
10
Defined genetic events associated with the spontaneous in vitro transformation of ElA/Ras-expressing human IMR90 fibroblasts.与表达E1A/Ras的人IMR90成纤维细胞自发体外转化相关的特定遗传事件。
Carcinogenesis. 2006 Feb;27(2):350-9. doi: 10.1093/carcin/bgi264. Epub 2005 Nov 9.

引用本文的文献

1
Hypoxia-induced metastatic heterogeneity in pancreatic cancer.缺氧诱导的胰腺癌转移异质性
bioRxiv. 2025 Aug 29:2025.08.26.672389. doi: 10.1101/2025.08.26.672389.
2
MYC Serine 62 phosphorylation promotes its binding to DNA double strand breaks to facilitate repair and cell survival under genotoxic stress.MYC丝氨酸62位点的磷酸化促进其与DNA双链断裂的结合,以在基因毒性应激下促进修复和细胞存活。
bioRxiv. 2025 Mar 20:2025.03.19.644227. doi: 10.1101/2025.03.19.644227.
3
Changes in spindle morphology driven by TPX2 overexpression in MYC-driven breast cancer cells.MYC驱动的乳腺癌细胞中TPX2过表达所驱动的纺锤体形态变化。
MicroPubl Biol. 2024 Apr 10;2024. doi: 10.17912/micropub.biology.001182. eCollection 2024.
4
Nuclear to cytoplasmic transport is a druggable dependency in MYC-driven hepatocellular carcinoma.核质转运是 MYC 驱动的肝细胞癌的可靶向依赖性。
Nat Commun. 2024 Feb 1;15(1):963. doi: 10.1038/s41467-024-45128-y.
5
Understanding DNA Epigenetics by Means of Raman/SERS Analysis for Cancer Detection.通过拉曼/ SERS 分析理解 DNA 表观遗传学以用于癌症检测。
Biosensors (Basel). 2024 Jan 12;14(1):41. doi: 10.3390/bios14010041.
6
Long non-coding RNA PVT1 (PVT1) affects the expression of CCND1 and promotes doxorubicin resistance in osteosarcoma cells.长链非编码RNA PVT1(PVT1)影响CCND1的表达并促进骨肉瘤细胞对阿霉素的耐药性。
J Bone Oncol. 2023 Nov 7;43:100512. doi: 10.1016/j.jbo.2023.100512. eCollection 2023 Dec.
7
MYC-driven synthesis of Siglec ligands is a glycoimmune checkpoint.MYC 驱动的 Siglec 配体的合成是一种糖免疫检查点。
Proc Natl Acad Sci U S A. 2023 Mar 14;120(11):e2215376120. doi: 10.1073/pnas.2215376120. Epub 2023 Mar 10.
8
Identification and Validation of a DNA Damage Repair-Related Signature for Diffuse Large B-Cell Lymphoma.鉴定和验证弥漫性大 B 细胞淋巴瘤的 DNA 损伤修复相关特征。
Biomed Res Int. 2022 Oct 14;2022:2645090. doi: 10.1155/2022/2645090. eCollection 2022.
9
MYC and therapy resistance in cancer: risks and opportunities.癌中的 MYC 与治疗抵抗:风险与机遇。
Mol Oncol. 2022 Nov;16(21):3828-3854. doi: 10.1002/1878-0261.13319. Epub 2022 Oct 20.
10
Phenformin Down-Regulates c-Myc Expression to Suppress the Expression of Pro-Inflammatory Cytokines in Keratinocytes.苯乙双胍下调 c-Myc 表达以抑制角质细胞中促炎细胞因子的表达。
Cells. 2022 Aug 5;11(15):2429. doi: 10.3390/cells11152429.

本文引用的文献

1
Gene amplification in a p53-deficient cell line requires cell cycle progression under conditions that generate DNA breakage.在p53基因缺陷的细胞系中,基因扩增需要在能产生DNA断裂的条件下细胞周期的进展。
Mol Cell Biol. 1998 May;18(5):3089-100. doi: 10.1128/MCB.18.5.3089.
2
MYC abrogates p53-mediated cell cycle arrest in N-(phosphonacetyl)-L-aspartate-treated cells, permitting CAD gene amplification.MYC消除了N-(膦酰乙酰基)-L-天冬氨酸处理的细胞中p53介导的细胞周期阻滞,使得CAD基因扩增。
Mol Cell Biol. 1998 Jan;18(1):536-45. doi: 10.1128/MCB.18.1.536.
3
Previously hidden chromosome aberrations in T(12;15)-positive BALB/c plasmacytomas uncovered by multicolor spectral karyotyping.多色光谱核型分析揭示的T(12;15)阳性BALB/c浆细胞瘤中先前隐藏的染色体畸变。
Cancer Res. 1997 Oct 15;57(20):4585-92.
4
Cyclin E and c-Myc promote cell proliferation in the presence of p16INK4a and of hypophosphorylated retinoblastoma family proteins.在存在p16INK4a和低磷酸化视网膜母细胞瘤家族蛋白的情况下,细胞周期蛋白E和c-Myc促进细胞增殖。
EMBO J. 1997 Sep 1;16(17):5322-33. doi: 10.1093/emboj/16.17.5322.
5
Myc represses the growth arrest gene gadd45.Myc抑制生长停滞基因gadd45。
Oncogene. 1997 Jun 12;14(23):2825-34. doi: 10.1038/sj.onc.1201138.
6
Genetic instability in colorectal cancers.结直肠癌中的基因不稳定性。
Nature. 1997 Apr 10;386(6625):623-7. doi: 10.1038/386623a0.
7
When checkpoints fail.当检查点失败时。
Cell. 1997 Feb 7;88(3):315-21. doi: 10.1016/s0092-8674(00)81870-x.
8
Synergy between the Mos/mitogen-activated protein kinase pathway and loss of p53 function in transformation and chromosome instability.Mos/丝裂原活化蛋白激酶途径与p53功能丧失在细胞转化和染色体不稳定性中的协同作用。
Mol Cell Biol. 1997 Jan;17(1):506-18. doi: 10.1128/MCB.17.1.506.
9
Uncoupling of DNA replication and cell cycle progression by human cyclin E.人细胞周期蛋白E使DNA复制与细胞周期进程解偶联。
Oncogene. 1996 Dec 5;13(11):2493-7.
10
Cell cycle checkpoints: preventing an identity crisis.细胞周期检查点:防止身份危机。
Science. 1996 Dec 6;274(5293):1664-72. doi: 10.1126/science.274.5293.1664.